HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells.

Abstract
Ten-eleven translocation (TET) family enzymes convert 5-methylcytosine to 5-hydroxymethylcytosine in DNA. However, the role of TET enzymes in human gastric cancer remains unknown. Here, we show that TET2 mRNA and protein levels are downregulated in human gastric cancer tissues when compared with normal gastric mucosa. Low expression of TET2 predicts poor overall and disease-free survival. Furthermore, we demonstrate that TET2 inhibits the proliferation and colony formation of human gastric cancer cells by using loss-of-function and gain-of-function strategies. Overexpression of TET2 induces apoptosis in human gastric cancer cells. The mechanism study shows that TET2 binds to the promoter region of the oncogenic long noncoding RNA (lncRNA-ANRIL) and regulates the expression of ANRIL and its downstream genes (INK4a, INK4b, and ARF). Finally, we demonstrate that ANRIL knockdown blocks the effects of TET2 on gastric cancer cell proliferation and colony formation. © 2016 IUBMB Life 68(5):355-364, 2016.
AuthorsWei Deng, Jin Wang, Jun Zhang, Jun Cai, Zhigang Bai, Zhongtao Zhang
JournalIUBMB life (IUBMB Life) Vol. 68 Issue 5 Pg. 355-64 (05 2016) ISSN: 1521-6551 [Electronic] England
PMID27027260 (Publication Type: Journal Article)
Copyright© 2016 International Union of Biochemistry and Molecular Biology.
Chemical References
  • CDKN2B antisense RNA, human
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • RNA, Long Noncoding
  • Dioxygenases
  • TET2 protein, human
Topics
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival
  • DNA-Binding Proteins (physiology)
  • Dioxygenases
  • Down-Regulation
  • Gene Expression
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Proto-Oncogene Proteins (physiology)
  • RNA, Long Noncoding (biosynthesis, genetics)
  • Stomach Neoplasms (metabolism, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: